Document is current
Any future updates will be listed below
-
Authors
Zhang, Yuezhou
Folarin, Amos A.
Ranjan, Yatharth
Cummins, Nicholas
Rashid, Zulqarnain
Conde, Pauline
Stewart, Callum
Sun, Shaoxiong
Vairavan, Srinivasan
Matcham, Faith
Oetzmann, Carolin
Siddi, Sara
Lamers, Femke
Simblett, Sara
Wykes, Til
Mohr, David C.
Haro, Josep Maria
Penninx, Brenda W. J. H.
Narayan, Vaibhav A.
Hotopf, Matthew
Dobson, Richard J. B.
Pratap, Abhishek
,
-
Funding
Funding for this research was provided by:
Innovative Medicines Initiative (115902, 115902, 115902)
- License Information
-
More Information
Article History
Received: 11 April 2024
Accepted: 11 March 2025
First Online: 18 April 2025
Competing interests
: S.V. is an employee of Janssen Research and Development LLC. V.A.N. was an employee of Janssen Research and Development LLC during the RADAR-MDD study. At the time of manuscript submission, A.P. is an employee of Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. M.H. is the principal investigator of the Remote Assessment of Disease and Relapse–Central Nervous System project, a public-private precompetitive consortium that receives funding from Janssen, UCB, Lundbeck, MSD, and Biogen. All other authors declare no competing interests.
